TrialBritish journal of haematology2014

A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.

Adlette Inati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.